Chawla Lakhmir S 4
4 · LA JOLLA PHARMACEUTICAL CO · Filed Sep 17, 2020
Insider Transaction Report
Form 4
Chawla Lakhmir S
Chief Medical Officer
Transactions
- Award
Common Stock
2020-09-15$3.85/sh+286$1,101→ 13,447 total - Award
Employee Stock Option (Right to Buy)
2020-09-15+286→ 286 totalExercise: $4.53Exp: 2030-09-15→ Common Stock (286 underlying) - Award
Employee Stock Option (Right to Buy)
2020-07-01+60,000→ 60,000 totalExercise: $4.52Exp: 2030-07-01→ Common Stock (60,000 underlying)
Footnotes (2)
- [F1]These shares were acquired on 09/15/2020 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]The stock options vest and become exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vest and become exercisable ratably on a monthly basis over the next three years.